Literature DB >> 24019677

Dual tracer functional characterization of metastatic gastric carcinoid.

Niraj Naswa1, Punit Sharma, Shipra Agarwal, Rakesh Kumar, Chandrashekhar Bal.   

Abstract

Because of the increasing clinical importance of gastric carcinoids and the difficulty in diagnosing them, the need for non-invasive diagnostic methods is growing. Currently, the only reliable method is upper gastrointestinal endoscopy with biopsy. We report the case of a 32-year-old male where a combination of functional imaging studies ((18)F-fluorodeoxyglucose-positron emission tomography/computed tomography [PET/CT] and (68)Ga-DOTA-NOC PET/CT) not only helped in the correct staging, but also highlighted certain important biological aspects of these tumors, which are important from the management point of view and can prognosticate the patients.

Entities:  

Keywords:  18F-fluorodeoxyglucose; 68Ga-DOTA-NOC; carcinoid; positron emission tomography/computed tomography; stomach

Year:  2013        PMID: 24019677      PMCID: PMC3764693          DOI: 10.4103/0972-3919.116817

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


  13 in total

1.  Evaluation of primary pulmonary carcinoid tumors using FDG PET.

Authors:  J J Erasmus; H P McAdams; E F Patz; R E Coleman; V Ahuja; P C Goodman
Journal:  AJR Am J Roentgenol       Date:  1998-05       Impact factor: 3.959

2.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

3.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

4.  Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

Authors:  G Rindi; C Bordi; S Rappel; S La Rosa; M Stolte; E Solcia
Journal:  World J Surg       Date:  1996-02       Impact factor: 3.352

Review 5.  Somatostatin receptor subtype expression in human tumors.

Authors:  L J Hofland; S W Lamberts
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

6.  ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis.

Authors:  G Rindi; C Azzoni; S La Rosa; C Klersy; D Paolotti; S Rappel; M Stolte; C Capella; C Bordi; E Solcia
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

Review 7.  Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.

Authors:  C J Gilligan; G P Lawton; L H Tang; A B West; I M Modlin
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

Review 8.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

9.  Clinical presentation and prognosis of gastrointestinal carcinoid tumours.

Authors:  S M Sjöblom
Journal:  Scand J Gastroenterol       Date:  1988-09       Impact factor: 2.423

10.  Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.

Authors:  O Nilsson; L Kölby; B Wängberg; A Wigander; H Billig; L William-Olsson; M Fjälling; E Forssell-Aronsson; H Ahlman
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.